Compare ADMA Biologics Inc (ADMA) vs Lithium Americas Corp (LAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Lithium Americas Corp — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Lithium Americas Corp trades at $3.27 (market cap $1.18B). The key difference: ADMA Biologics Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| ADMA | LAC | |
|---|---|---|
Market Cap | $2.22B | $1.18B |
Sector | Health | Basic Materials |
52-Week High | $20.38 | $10.05 |
52-Week Low | $7.60 | $2.71 |
Enterprise Value | $2.29B | $1.29B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Lithium Americas Corp
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →
